AR226-2593 Mark Houlday 08/16/2002 12:44:54 PM To: Isdoras J Zanikos/AE/DuPont@DuPont cc: Andrew S Hartten/AE/DuPont@DuPont Subject: Washington Works Talking Points Izzy here are some topics that you may wish to discuss: GIST Meeting - went well.
refid# GmQxGNevamN9RM7gLJBG9BoEV1 page
DuPont will submit a summaryofthe results when they become available.
refid# 4aymz99rrbkmg7b97jMOzxMdN2 pages
Debbie J Mulrooney Debbie J Mulrooney ' 11/29/2001 08:41 AM To: Chris E Shoop/AE/DuPont@DuPont cc: Subject: Revised Spreadsheet - Chris, One more question for you.
refid# Y9eeyDz8bxEv0NmO0jLnabLjN1 page
Therefore, 3M would have no objection to my assisting Dupont provided we maintain confidentially between the two companies and that Dupont does not disqualify me as a potential expert for 3M.
refid# RJKbNjejkJ9nV8x2EDR2rZnB1 page
`While DuPont does not believe that the information submitted with this letter triggers reporting obligations under TSCA section 8(), DuPont is forwarding this information to EPA in lightoftheAgency's continued interest in PFOA.
refid# 06vkdZpGzBZj5y8dkMkDVXdbO1 page
Page 2012 Attachment 1 PUBLIC COPY + DuPont US.
refid# dqo2zDZJp4rz1GmvpwmxybY92 pages
DuPont de Nemours and Company, Inc.
refid# gDB2mz6aNpN4yGoy7qeoVBR5Q2 pages
Buck - DuPont Chemical Solutions Enterprise P.
refid# 44Lg3NzMy4qmBG3B2Ry0Y45M11 page
Attachment II DuPont Statistical Analysis of Serum Lipid Data of Miteni Workers Confidential DuPont Draft Work Product Confidential DuPont Draft Work Product Confidential DuPont Draft Work Product LO G _LD L vs LO G _PFCV\ : 2 0 0 4 3. s.s 3.4 Slcpe p --m lu e LOG_P FOA = Q 02 5.5 $.2 t * S.1 m ft D O"u*1A*i1 J 4.z 4.7 4.44.5 4.4 4.5 4.2-1 .* * dI Z3 LPE-FfM LDG _LDL vs LO G _PFC A : 2 0 0 3 3.4 S.S Slope p --m lue LOS PFOA = 0.83 S.2 S.1 * 3.3 a 4.4 U 3 44 ^ 4.7 4.4 4.4' p V 4.4: 4,41 0 IZ3 L&E.FFDA 4 * 4 L O G _ L D L v s L O G _ P F Q fli : 2 0 0 2 3.1- 5.5- 3.7' Slope p--value LOG_PFCA = 0.07 5.5- 5.53.45.3- 5.1- , wm a r m . 3 5,0t.4.5 4.7 4.5 4.54.44.3- 1 * 1 1 ' ill"1 p * p i s -l -1 4 1 Z i 10C-PFM .* P * ft 45 L O G _ L D L v s L O G _ P F Q fli : 2 0 0 1 5.*- 5.3Slope p --value LOG PFCA = 0 .6 4 5.Z- * * mm m . m 3.1: 3.D o 4 .$ 1 3+5: 4.7: 4 .
refid# gDYN795QDYq8XRy8jb2Q9dp5e20 pages
AR226-3186 TRADE SECRET Study Title H-24616: Subchronic T oxicity 90-Day Gavage Study in Rats with One-Generation Reproduction Evaluations Volume 3 o f 5 Laboratory Project ID: DuPont-4739 DuPont-4739 Test Guidelines: U .S.
refid# oMoRNQjmBEkqgywZo2v6E4em3331 pages
DuPont Specialty Chemicals E.
refid# g2Q43z2QOgJyVdK45x2ZdjZE338 pages
The historical C-S data compilation report was submitted to the GIST for evaluation (DuPont. 2002b).
refid# 3NeawJqYRdn08D2M6148wKB3x28 pages
Senior Research Scientist 3 ~ ) e c ~ -3o 1 Date Applicant / Sponsor:____________________________ ___________ __________ DuPont Representative Date S a u t e d .
refid# Lpk7385J7vV0DxM8w9XJozmOw316 pages
Senior Research Scientist Applicant / Sponsor: DuPont Representative Date Date Company Sanitized.
refid# 2YRGOVaqDOy9xoqDD2Ge74eb317 pages
AR226-3192 DuPont-6541 TRADE SECRET Study Title H-24951: Biopersistence Screening 10-Dose Oral Gavage Study in Rats Laboratory Project ID: DuPont-6541 Author: Carol Finlay, B.A.
refid# O1wL15Ge55QEza40YMV4ngL8X84 pages